First-Line Therapeutic Strategies in Metastatic Colorectal Cancer The Davies/Goldberg Article Reviewed

被引：0
|
作者：
Turja, Joleen [1 ]
Grothey, Axel [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
ONCOLOGY-NEW YORK | 2008年 / 22卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1479 / 1481
页数：3
相关论文
共 50 条
  • [41] First-line therapy for metastatic colorectal cancer: Current perspectives and future directions
    Burge, Matthew
    Price, Timothy
    Karapetis, Christos S.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 3 - 14
  • [42] FOLFOX7 regimen in the first-line treatment of metastatic colorectal cancer
    Koca, Dogan
    Unal, Olcun Umit
    Oztop, Ilhan
    Yilmaz, Ugur
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (02): : 198 - 204
  • [43] Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
    Strickler, John H.
    Hurwitz, Herbert I.
    [J]. ONCOLOGIST, 2012, 17 (04): : 513 - 524
  • [44] The prognostic impact of NKA dynamics in first-line treatment of metastatic colorectal cancer
    Nederby, Line
    Raunkilde, Louise
    Jakobsen, Anders
    Jensen, Lars Henrik
    Havelund, Birgitte Mayland
    Wen, Sara Witting Christensen
    Hansen, Torben
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer
    Ravaioli, A
    Marangolo, M
    Pasquini, E
    Rossi, A
    Amadori, D
    Cruciani, G
    Tassinari, D
    Oliverio, G
    Giovanis, P
    Turci, D
    Zumaglini, F
    Nicolini, M
    Panzini, I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2545 - 2550
  • [46] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    M J Safont
    A Salud
    F Losa
    C García-Girón
    C Bosch
    P Escudero
    R López
    C Madroñal
    M Bolaños
    M Gil
    A Llombart
    J Castro-Carpeño
    M González-Barón
    [J]. British Journal of Cancer, 2010, 102 : 1468 - 1473
  • [47] First-line chemotherapy with raltitrexed in metastatic colorectal cancer: An AGEO multicentre study
    Gallois, C.
    Hafliger, E.
    Auclin, E.
    Perret, A.
    Artru, P.
    Coutzac, C.
    Turpin, A.
    Pellat, A.
    Randrian, V.
    Basile, D.
    Faroux, R.
    Locher, C.
    Hautefeuille, V.
    Dubreuil, O.
    Palmieri, L-J.
    Dior, M.
    Taieb, J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S430 - S430
  • [48] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    [J]. JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [49] Bevacizumab in combination with chemotherapy: First-line treatment of patients with metastatic colorectal cancer
    Hochster, Howard S.
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (05) : S8 - S14
  • [50] First-Line Therapy in Metastatic Colorectal Cancer Patients Not Candidates for Curative Surgery
    Murad, Andre M.
    Murad, Lucas S.
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2015, 11 (02) : 54 - 69
12345